| IPF | Idiopathic pulmonary fibrosis |
| UIP | Usual interstitial pneumonia |
| LC | Lung cancer |
| LC-IPF | Lung cancer associated with idiopathic pulmonary fibrosis |
| NSCLC | Non-small cell-lung cancer |
| ADC | Adenocarcinoma |
| SQC | Squamous cell carcinoma |
| SCLC | Small cell lung cancer |
| ATII | Alveolar type II cells |
| ECM | Extracellular matrix |
| EMT | Epithelial to mesenchymal transition |
| EndMT | Endothelial to mesenchymal transition |
| α-SMA | α-smooth muscle actin |
| CAF | Cancer-associated fibroblast |
| ER | Endoplasmic reticulum stress |
| TGFβ | Transforming growth factor β |
| FGF | Fibroblast growth factor |
| VEGF | Vascular endothelial growth factor |
| PDGF | Platelet derived growth factor |
| IL-13 | Interleukin-13 |
| CCL2 | Chemokine ligand 2 |
| CCR2 | Chemokine receptor 2 |
| BALF | Bronchoalveolar lavage fluid |
| LPA | Lysophosphatidic acid |
| LPAR1 | Lysophosphatidic acid receptor 1 |
| ATX | Autotaxin |
| Shh | Sonic hedhehog |
| TKI | Tyrosine kinase inhibitor |
| EGFR | Epidermal growth factor |